Page last updated: 2024-11-07

spironolactone and Experimental Mammary Neoplasms

spironolactone has been researched along with Experimental Mammary Neoplasms in 2 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Luthy, IA1
Begin, DJ1
Labrie, F1
Kovacs, K1
Somogyi, A1

Other Studies

2 other studies available for spironolactone and Experimental Mammary Neoplasms

ArticleYear
Androgenic activity of synthetic progestins and spironolactone in androgen-sensitive mouse mammary carcinoma (Shionogi) cells in culture.
    Journal of steroid biochemistry, 1988, Volume: 31, Issue:5

    Topics: Androgens; Animals; Cell Division; Chlormadinone Acetate; Dihydrotestosterone; Flutamide; Male; Mamm

1988
Suppression by spironolactone of 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
    European journal of cancer, 1970, Volume: 6, Issue:3

    Topics: Adrenal Glands; Animals; Benz(a)Anthracenes; Biotransformation; Female; Liver; Mammary Neoplasms, Ex

1970